Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target.
about
Potential approaches to the treatment of Ewing's sarcomaSézary syndrome: old enigmas, new targets.Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma.Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas.Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX models.[Treatment of mycosis fungoides and Sézary syndrome].
P2860
Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Aurora Kinase A Is Upregulated ...... Potential Therapeutic Target.
@en
type
label
Aurora Kinase A Is Upregulated ...... Potential Therapeutic Target.
@en
prefLabel
Aurora Kinase A Is Upregulated ...... Potential Therapeutic Target.
@en
P2093
P356
P1476
Aurora Kinase A Is Upregulated ...... a Potential Therapeutic Target
@en
P2093
Ahmed Haider
Chalid Assaf
Cyprienne Isabell Geilen
Daniel Humme
Hanako Ohmatsu
Hiroshi Mitsui
Ioannis Anagnostopoulos
James G Krueger
Jürgen Eberle
Marc Beyer
P2888
P304
P356
10.1038/JID.2015.139
P407
P50
P577
2015-04-07T00:00:00Z
P6179
1043501571